An observational study in Acute Kidney Injury in the ICU, sponsored by Meir Medical Center. Not yet recruiting at 1 site in Israel. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by Meir Medical Center · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Acute Kidney Injury with a site in Israel — 3 open to participants now, 4 under way, none of them phase 3. Acute Kidney Injury · Israel.
Among the 13 studies in Acute Kidney Injury with a site in Israel, this one is the only one that started in 2027, is one of 6 observational ones, and was the 9th registered.
1,693 studies on the registry are indexed under Acute Kidney Injury; 392 are open to participants now.
Browse Acute Kidney Injury studies →3 of the 13 studies in Acute Kidney Injury with a site in Israel are open now. Recruiting first, the newest first:
FIZE Medical ltd · Sites in Israel
Ages 18+
Indiana University · Sites in Israel, United States, Argentina and 30 more countries
Ages 0 min–2 wk
A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →
Of the 229 Acute Kidney Injury studies recruiting now, 161 (70%) set no upper age limit and 35 (15%) stop at 75 or younger; 22 take children under 18; 25 take healthy volunteers.
This study: 18 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 1 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,800 is above the median of 160 across 814 observational studies indexed under Acute Kidney Injury.
Median enrollment 30 across the 7 interventional studies, 250 across the 6 observational. Of the 7 that completed or were terminated, 1 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 13 have an industry lead sponsor. The 10 most frequent:
Meir Medical Center is the lead sponsor of 402 studies on the registry; 26 are open to participants now.
Meir Medical Center has 1 study filed under Acute Kidney Injury — fewer than ten, so there is no comparison to draw.
2 of the studies in Acute Kidney Injury with a site in Israel that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06823115Indiana UniversityAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 | 2027-01 |
| NCT07022314FIZE Medical ltdUrine Output Response to Fluid and Diuretic Therapy in Cardiac ICU Patients Monitored With FIZE kUO® | 2027-06 |
Add all 2 to your calendar (.ics) → With an account.
Among the 13 studies in Acute Kidney Injury with a site in Israel, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Acute kidney injury is common among ICU-admitted patients, and is associated with increased morbidity and mortality. Early recognition is essential to prevent complications. In this study we aim to examine whether strict monitoring of urine output may reduce the incidence of acute kidney injury, allow for less positive fluid balance and reduce the clinical symptoms of fluid overload in ICU patients. Currently we monitor urine output using a Urinometer, with manual recording. From June 2022 we will begin routine use of an automated urine monitoring system in the ICU and test its effect on the parameters listed above. We will conduct a before-after retrospective intervention. The group of patients in whom the automated system will be used, from June 2022 to January 2024, will be the study group. The patients admitted to the ICU in the period between January 2021 and June 2022 will be the control group. We will include patients aged 18-100, who were admitted to the General Intensive Care Unit in Meir Medical Center from January 2021 to January 2024, and had admission time longer than 48 hours. Patients without a urinary catheter will not be included. The study will be conducted in the format of observational data collection from hospital files and computerized systems (Metavision system and Chameleon system). We estimate that we will include about 900 patients in the study group and about 900 in the control group. All demographic and inpatient data will be statistically examined by a qualified statistician depending on the type of data.
Patients aged 18-100, who were admitted to the General Intensive Care Unit in Meir Medical Center from January 2021 to January 2024
Inclusion Criteria: Patients aged 18-100, who were admitted to the General Intensive Care Unit in Meir Medical Center from January 2021 to January 2024, and had admission times longer than 48 hours.
-
Exclusion Criteria: Patients without a urinary catheter, Patients with admission times less than 48 hours.
-
Drug: Automated urinary output collection system group (tight monitoring of urine output)
Automated urinary output collection system group (tight monitoring of urine output)
Prevalence of acute kidney injury
Primary outcome: To investigate whether the use of an automatic urinary output monitoring system in ICU patients will decrease the incidence of acute kidney injury
Time frame: June 2023-January 2024
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2027; primary completion for Jan 2029, 13 months later.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 9, 2026: start Dec 2025 → Dec 2027, primary completion Jan 2026 → Jan 2029 and completion Jun 2026 → Jun 2029.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.